28595-310-16 : NDC 2026 Code

28595-310-16 : Dextromethorphan Hbr, Pseudoephedrine Hci, And Triprolidine Hci ( Histex-dm New Formulation )

Additionally :

You can get information about “28595-310-16” NDC code in 28595-310-16 in HTML format

HTML | 28595-310-16 in TXT (Plain Text) format

TXT | 28595-310-16 in PDF (Portable Document Format)

PDF | 28595-310-16 in XML format

XML formats.

NDC Code : 28595-310-16 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "28595-310-16",
    "PackageDescription": "473 mL in 1 BOTTLE (28595-310-16) ",
    "NDC11Code": "28595-0310-16",
    "ProductNDC": "28595-310",
    "ProductTypeName": "HUMAN OTC DRUG",
    "ProprietaryName": "Histex-dm New Formulation",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Dextromethorphan Hbr, Pseudoephedrine Hci, And Triprolidine Hci",
    "DosageFormName": "SYRUP",
    "RouteName": "ORAL",
    "StartMarketingDate": "20250310",
    "EndMarketingDate": null,
    "MarketingCategoryName": "OTC MONOGRAPH DRUG",
    "ApplicationNumber": "M012",
    "LabelerName": "Allegis Pharmaceuticals, LLC",
    "SubstanceName": "DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE",
    "StrengthNumber": "20; 30; 2.5",
    "StrengthUnit": "mg/5mL; mg/5mL; mg/5mL",
    "Pharm_Classes": "Adrenergic alpha-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-03-11",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20250310",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}